ArticleIn silico pharmacology2026

Piceid as a promising candidate for multi-target adjunctive therapeutic for inflammation-associated cervical cancer progression: an in silico approach.

Shamanth D Harishkumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.